Mustang Bio News and Activities

Mustang Bio is owned by Fortress Biotech.

Fortress Biotech is a company listed under the stock ticker FBIO (US).

Fortress Biotech has 4 subsidiaries including Avenue Therapeutics, Checkpoint Therapeutics and Journey Medical Corp.

They are in:

• Biotechnology80%
• Pharmaceuticals20%

View the org chart displaying its 11 main executives

Most searched biographies at Mustang Bio

• Manny Litchman, President, Chief Executive Officer and Director
• David Jin, Director
• Michael Zelefsky, Director

Popular executive movements at Fortress Biotech

• George Avgerinos, Senior Vice President, Biologics Operations, has left the company  (posted on November 28 2025).

Create your alert
to follow the executive moves at Mustang Bio.

Fortress Biotech has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Mustang Bio

• Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
• Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
• Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
• Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
• Mustang Bio Announces Pricing of $8 Million Public Offering
• Mustang Bio Announces Closing of $8 Million Public Offering
• Mustang Bio Announces Reverse Stock Split
• Press Releases
• Mustang Bio Receives Positive Listing Determination from Nasdaq
• Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
• View more press releases Close

Social media about Mustang Bio

• Mustang Bio on Wikipedia, Google News & Yahoo Finance
• Mustang Bio on LinkedIn, X (Twitter) & YouTube